QIAGEN NV (QGEN)

38.76
0.25 0.65
NYSE : Health Technology
Prev Close 38.51
Open 38.58
Day Low/High 38.40 / 38.84
52 Wk Low/High 32.33 / 41.55
Volume 899.03K
Avg Volume 1.27M
Exchange NYSE
Shares Outstanding 226.97M
Market Cap 8.41B
EPS 0.80
P/E Ratio 46.35
Div & Yield N.A. (N.A)

Latest News

Inovio And QIAGEN Establish Collaboration To Develop Diagnostic Test For VGX-3100, Inovio's Novel Immunotherapy Targeting Advanced Cervical Pre-Cancer

Inovio And QIAGEN Establish Collaboration To Develop Diagnostic Test For VGX-3100, Inovio's Novel Immunotherapy Targeting Advanced Cervical Pre-Cancer

Liquid biopsy-based Precision Medicine test to guide patient selection for Inovio's VGX-3100

QIAGEN Posts 2018 Annual Report On Its Website

QIAGEN Posts 2018 Annual Report On Its Website

QIAGEN N.V.

QIAGEN N.V. To Report First Quarter 2019 Results

QIAGEN N.V. To Report First Quarter 2019 Results

QIAGEN N.V.

QIAGEN Launches QCI Interpret Bioinformatics Features For Use For Blood Cancers As Well As A Novel Myeloid Gene Panel For GeneReader NGS System

QIAGEN Launches QCI Interpret Bioinformatics Features For Use For Blood Cancers As Well As A Novel Myeloid Gene Panel For GeneReader NGS System

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of two novel products to deliver actionable insights on a wide range of blood cancers: a new workflow for the QIAGEN Clinical Insight (QCI) Interpret bioinformatics solution for...

TheStreet Quant Rating: B (Buy)